Accessing Contractility of 3D iPSC-derived Engineered Muscle Tissues at High-throughput Using a Novel, Label-free Method

Time: 2:00 pm
day: Day One

Details:

Overview of the technology, along with application examples across various use cases, including:

  • Skeletal muscle applications that can achieve tetanic contractions and fatigability, as well as stain positively for muscle specific markers, including fast myosin and desmin.
  • Disease models generated from iPSCs – including patients with rare diseases such as muscular dystrophy – and tested on the platform

Speakers: